Brain MRI Surveillance Cuts Cognitive Risk in SCLC Without PCI

Organ Mutation Rates Explain Cancer Risk Differences

Patients with small-cell lung cancer (SCLC) undergoing regular brain MRI surveillance without prophylactic cranial irradiation (PCI) achieved significantly better cognitive failure–free survival, according to phase III randomized trial results presented at the Presidential Symposium of the IASLC 2026 World Conference on Lung Cancer in Seoul, Republic of Korea. Researchers reported that MRI surveillance alone improved … Read more

MD Anderson Trial Challenges NSCLC Local Consolidative Therapy Paradigm

Adding local consolidative therapy after induction treatment with nivolumab plus ipilimumab does not improve overall survival or progression-free survival in patients with metastatic non-small cell lung cancer, including those with oligometastatic disease, according to phase III trial results presented at the International Association for the Study of Lung Cancer 2026 World Conference on Lung Cancer. … Read more

Thymus Radiation Linked to Worse Lung Cancer Survival, Study Finds

Organ Mutation Rates Explain Cancer Risk Differences

Radiation exposure to the thymus during non-small cell lung cancer treatment is associated with worse outcomes in patients being treated for non-small cell lung cancer (NSCLC), according to a study published in the journal Annals of Oncology. Thymus Health and Radiation Risks in NSCLC Patients Until recently, the thymus was thought to be of little … Read more

Don’t Ignore Lingering Lung Symptoms: A Warning for Regional WA

The Cancer Council WA has launched the “It is time to act” campaign to address a stark disparity in lung cancer outcomes between Western Australia’s metropolitan and regional populations. Data from the WA Cancer Registry shows that between 2018 and 2022, the five-year survival rate for lung cancer was 35 per cent in metropolitan Perth, … Read more

Smoking and Cardiovascular Risks: What Smokers Miss

A new international study reveals that global tobacco control campaigns have failed to bridge a critical knowledge gap over two decades, leaving millions of smokers unaware that tobacco causes heart attacks, strokes, and cardiovascular disease. According to research published in BMJ Open by teams at the University of Waterloo and the U.S. Centers for Disease … Read more

Lung Cancer in Non-Smokers: Hidden Risk Factors You Need to Know

Lung cancer is no longer exclusively a smoker’s disease, as rising global incidence rates and clinical observations challenge long-held medical assumptions. Worldwide, approximately 2.5 million people were diagnosed with lung cancer annually in 2022, reflecting an age-adjusted standardized ratio of roughly 24 cases per 100,000 people. While male incidence rates have declined across most countries … Read more

Rising Lung Cancer in Non-Smokers in India: Causes and Risks

Lung cancer diagnoses are rising among non-smokers, driven by severe air pollution, indoor biomass smoke, second-hand tobacco exposure, and specific genetic mutations according to medical experts. Oncologists report that this shift challenges the long-held perception that tobacco is the sole cause of the disease, leaving many patients facing delayed diagnoses because persistent respiratory symptoms are … Read more

Viagra Ingredient Stops Cancer Spread in World First Study

< div> According to peer-reviewed research published in July in Cancer Research, sildenafil—the active ingredient in Viagra—disrupts cancer cells’ cholesterol supply to stop the spread of metastases. Researchers at the Weizmann Institute of Science, alongside teams from the US National Cancer Institute and Clalit Health Services, found that the drug targets the protein transporting essential … Read more

COVID-19 Tech Inspires New Cancer Vaccine Platform

A new dendritic cell vaccine platform known as PROTEXI redirects pre-existing antiviral immune memories from SARS-CoV-2 infections or vaccinations to help the immune system recognize and eliminate therapy-resistant tumors, according to a study published in Nature Communications by researchers from Celloram Inc, University Hospitals, and Case Western Reserve University. Redirecting Pandemic Immunity Against Solid Tumors … Read more

Genetic Susceptibility and Cancer Progression: What New Research Reveals

Inherited genetics directly shape how our DNA interacts with acquired mutations to drive tumor evolution, according to research published in Nature. Scientists at the University of Cambridge and the University of Edinburgh found that an individual’s genetic background dictates both cancer risk and the specific evolutionary paths tumors take, offering new direction for precision medicine … Read more